PALVELLA THERAPEUTICS, INC. (PVLA) Institutional Shareholders
PALVELLA THERAPEUTICS, INC. (PVLA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.14B in PVLA holdings during the latest filing period.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of PVLA tracked by InsiderSet, reporting ownership valued at approximately $173.51M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $170.95M, representing an estimated loss of -1.48% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed PVLA value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Jennison Associates Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in PALVELLA THERAPEUTICS, INC. (PVLA).
This page ranks the largest institutional PVLA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
191
Total Reported Value
$2.14B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$173.51M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
94
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 3.65% | 1,135,406 | $173,512,745 | $170,946,727 | -$2,566,018 | -1.48% | |
| Jennison Associates Llc | 0.09% | 960,619 | $146,801,795 | $144,630,797 | -$2,170,998 | -1.48% | |
| Blackrock, Inc. | 0.00% | 918,357 | $140,343,317 | $138,267,830 | -$2,075,487 | -1.48% | |
| Frazier Life Sciences Management, L.P. | 2.94% | 882,400 | $134,848,368 | $132,854,144 | -$1,994,224 | -1.48% | |
| First Light Asset Management, Llc | 7.17% | 771,901 | $117,961,911 | $116,217,415 | -$1,744,496 | -1.48% | |
| Bvf Inc/Il | 2.63% | 672,789 | $102,815,615 | $101,295,112 | -$1,520,503 | -1.48% | |
| State Street Corp | 0.00% | 653,172 | $99,817,745 | $98,341,576 | -$1,476,169 | -1.48% | |
| Price T Rowe Associates Inc | 0.01% | 638,868 | $97,632,000 | $96,187,966 | -$1,444,034 | -1.48% | |
| Vanguard Capital Management Llc | 0.00% | 513,794 | $78,517,999 | $77,356,825 | -$1,161,174 | -1.48% | |
| Frontier Capital Management Co Llc | 0.68% | 478,833 | $73,175,272 | $72,093,096 | -$1,082,176 | -1.48% | |
| Federated Hermes, Inc. | 0.10% | 433,015 | $66,173,352 | $65,194,738 | -$978,614 | -1.48% | |
| Woodline Partners Lp | 0.15% | 317,517 | $48,522,948 | $47,805,360 | -$717,588 | -1.48% | |
| Orbimed Advisors Llc | 0.85% | 292,360 | $44,678,455 | $44,017,722 | -$660,733 | -1.48% | |
| Geode Capital Management, Llc | 0.00% | 276,164 | $42,213,033 | $41,579,252 | -$633,781 | -1.50% | |
| Siren, L.L.C. | 0.80% | 257,485 | $39,348,858 | $38,766,942 | -$581,916 | -1.48% | |
| Primecap Management Co/Ca/ | 0.02% | 256,182 | $39,149,734 | $38,570,762 | -$578,972 | -1.48% | |
| Eventide Asset Management, Llc | 0.47% | 231,484 | $35,375,385 | $34,852,231 | -$523,154 | -1.48% | |
| Emerald Advisers, Llc | 0.83% | 229,486 | $35,070,051 | $34,551,412 | -$518,639 | -1.48% | |
| Fmr Llc | 0.00% | 214,841 | $32,831,927 | $32,346,461 | -$485,466 | -1.48% | |
| Alliancebernstein L.P. | 0.01% | 253,168 | $31,557,391 | $38,116,974 | +$6,559,583 | +20.79% | |
| Mpm Bioimpact Llc | 1.90% | 204,027 | $31,179,406 | $30,718,305 | -$461,101 | -1.48% | |
| Goldman Sachs Group Inc | 0.00% | 201,514 | $30,795,370 | $30,339,948 | -$455,422 | -1.48% | |
| Morgan Stanley | 0.00% | 181,428 | $27,725,827 | $27,315,800 | -$410,027 | -1.48% | |
| First Turn Management, Llc | 2.56% | 156,450 | $23,908,689 | $23,555,112 | -$353,577 | -1.48% | |
| Bellevue Group Ag | 0.50% | 155,000 | $23,687,100 | $23,336,800 | -$350,300 | -1.48% | |
| Emerald Mutual Fund Advisers Trust | 0.70% | 129,847 | $19,843,219 | $19,549,764 | -$293,455 | -1.48% | |
| Vanguard Portfolio Management Llc | 0.00% | 128,962 | $19,707,973 | $19,416,519 | -$291,454 | -1.48% | |
| Aberdeen Group Plc | 0.03% | 120,238 | $18,374,771 | $18,103,033 | -$271,738 | -1.48% | |
| Northern Trust Corp | 0.00% | 97,193 | $14,853,034 | $14,633,378 | -$219,656 | -1.48% | |
| Nextbio Capital Management Lp | 6.32% | 89,909 | $13,739,893 | $13,536,699 | -$203,194 | -1.48% | |
| Clio Asset Management Llc | 10.49% | 86,343 | $13,194,937 | $12,999,802 | -$195,135 | -1.48% | |
| Neuberger Berman Group Llc | 0.01% | 83,107 | $12,700,411 | $12,512,590 | -$187,821 | -1.48% | |
| Vanguard Fiduciary Trust Co | 0.00% | 73,995 | $11,307,916 | $11,140,687 | -$167,229 | -1.48% | |
| Ubs Group Ag | 0.00% | 72,526 | $11,083,424 | $10,919,515 | -$163,909 | -1.48% | |
| Avidity Partners Management Lp | 1.71% | 70,000 | $10,697,400 | $10,539,200 | -$158,200 | -1.48% | |
| Awm Investment Company, Inc. | 0.92% | 69,416 | $10,608,153 | $10,451,273 | -$156,880 | -1.48% | |
| Seven Grand Managers, Llc | 0.37% | 60,000 | $9,169,200 | $9,033,600 | -$135,600 | -1.48% | |
| Clearbridge Investments, Llc | 0.01% | 59,341 | $9,068,458 | $8,934,381 | -$134,077 | -1.48% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 69,901 | $8,713,159 | $10,524,295 | +$1,811,136 | +20.79% | |
| Bank Of America Corp | 0.00% | 54,554 | $8,336,942 | $8,213,650 | -$123,292 | -1.48% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 53,270 | $8,140,721 | $8,020,331 | -$120,390 | -1.48% |
| Millennium Management Llc | 0.01% | 52,212 | $7,979,038 | $7,861,039 | -$117,999 | -1.48% | |
| Hsbc Holdings Plc | 0.00% | 50,001 | $7,641,156 | $7,528,151 | -$113,005 | -1.48% | |
| Nicholas Investment Partners, Lp | 0.43% | 49,718 | $7,597,905 | $7,485,542 | -$112,363 | -1.48% | |
| Balyasny Asset Management L.P. | 0.01% | 44,536 | $6,805,992 | $6,705,340 | -$100,652 | -1.48% | |
| Lisanti Capital Growth, Llc | 1.44% | 42,975 | $6,567,440 | $6,470,316 | -$97,124 | -1.48% | |
| Wcm Investment Management, Llc | 0.01% | 40,140 | $6,215,278 | $6,043,478 | -$171,800 | -2.76% | |
| Royce & Associates Lp | 0.05% | 40,509 | $6,190,585 | $6,099,035 | -$91,550 | -1.48% | |
| Silvercrest Asset Management Group Llc | 0.04% | 39,865 | $6,092,169 | $6,002,074 | -$90,095 | -1.48% | |
| Jump Financial, Llc | 0.05% | 39,413 | $6,023,095 | $5,934,021 | -$89,074 | -1.48% |
Frequently asked questions about PVLA
Who owns the most PVLA stock?
The largest holders of PVLA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PALVELLA THERAPEUTICS, INC. (PVLA).
Is PVLA widely held by superinvestors?
Many widely followed stocks like PVLA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PVLA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.